Pharmaceuticals news FT.com

AstraZeneca sales jump despite troubles in China

FTSE’s most valuable company faces potential fine over suspected unpaid taxes in country

Feb 9, 2025 - 22:26
 0
AstraZeneca sales jump despite troubles in China
FTSE’s most valuable company faces potential fine over suspected unpaid taxes in country
Read More

Tags:

Previous Article

Eli Lilly expects to beat profit forecasts on obesity drug demand

Next Article

Obesity drug sales surge at Novo Nordisk

Related Posts

Novo Nordisk shares jump up on latest weight-loss drug trial results

Novo Nordisk shares jump up on latest weight-loss drug ...

Feb 9, 2025  0

Eli Lilly unveils $27bn US investment as corporate America seeks to woo Trump

Eli Lilly unveils $27bn US investment as corporate Amer...

Feb 26, 2025  0

Rapid trials prompt deals rush for Chinese ‘super me-too’ drugs

Rapid trials prompt deals rush for Chinese ‘super me-to...

Feb 9, 2025  0